NASDAQ:TCBP TC Biopharm (TCBP) Stock Price, News & Analysis $0.87 +0.01 (+1.16%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.84▼$0.9050-Day Range$0.73▼$1.1752-Week Range$0.72▼$19.60Volume41,791 shsAverage Volume2.47 million shsMarket Capitalization$7.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrends Get TC Biopharm alerts: Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About TC Biopharm Stock (NASDAQ:TCBP)TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.Read More TCBP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TCBP Stock News HeadlinesJuly 22, 2024 | finance.yahoo.comTCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid LeukemiaJuly 22, 2024 | prnewswire.comTCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid LeukemiaJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 15, 2024 | prnewswire.comTCBP Announces Launch of Compassionate Use Program for TCB008May 6, 2024 | prnewswire.comTC BioPharm Announces Exercise of Warrants for £3.1 Million Gross ProceedsMay 6, 2024 | investorplace.comWhy Is TC Biopharm (TCBP) Stock Up 51% Today?May 6, 2024 | markets.businessinsider.comTC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy InnovatorMay 6, 2024 | prnewswire.comTC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 6, 2024 | uk.investing.comTC BioPharm eyes expansion with CAR-NK technology LOIApril 4, 2024 | msn.comHyosung invests $1bn in green raw materials for ‘bio-spandex’April 4, 2024 | marketwatch.comTC BioPharm Shares Rise 63% After Letter Intent to Buy Cancer Therapy AssetsApril 4, 2024 | investorplace.comWhy Is TC Biopharm (TCBP) Stock Up 78% Today?April 4, 2024 | markets.businessinsider.comTC BioPharm Enters Non-Binding Letter Of Intent For Acquisition Of NK Platform TechnologiesApril 4, 2024 | finance.yahoo.comTCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesApril 2, 2024 | prnewswire.comTCBP Increasing Treatment Capacity with Expanded Manufacturing ProcessMarch 19, 2024 | finance.yahoo.comTCBP Adjourns General Meeting Until a Later DateMarch 18, 2024 | finance.yahoo.comTCBP Announces Exercise of Series D Warrants For CashSee More Headlines Receive TCBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TCBP CUSIPN/A CIK1872812 Webwww.tcbiopharm.com Phone44-14-1433-7557FaxN/AEmployees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.31 Current Ratio0.88 Quick Ratio0.88 Sales & Book Value Annual Sales$4.76 million Price / Sales1.54 Cash FlowN/A Price / Cash FlowN/A Book Value$3.25 per share Price / Book0.27Miscellaneous Outstanding Shares8,450,000Free Float7,141,000Market Cap$7.35 million OptionableNot Optionable Beta0.07 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Bryan L. Kobel (Age 45)CEO & Director Mr. Martin E. Thorp (Age 72)CFO & Director Mr. Christopher CamarraExecutive Vice President of CommunicationsDr. Lauren Bor Ph.D.Head of Commercial Development DivisionKey CompetitorsOncoCyteNASDAQ:OCXNRx PharmaceuticalsNASDAQ:NRXPMEI PharmaNASDAQ:MEIPBrainstorm Cell TherapeuticsNASDAQ:BCLIHCW BiologicsNASDAQ:HCWBView All Competitors TCBP Stock Analysis - Frequently Asked Questions How have TCBP shares performed this year? TC Biopharm's stock was trading at $3.17 at the beginning of the year. Since then, TCBP shares have decreased by 72.6% and is now trading at $0.87. View the best growth stocks for 2024 here. How were TC Biopharm's earnings last quarter? TC Biopharm (Holdings) Plc (NASDAQ:TCBP) announced its quarterly earnings data on Wednesday, May, 15th. The company reported ($2.80) earnings per share (EPS) for the quarter. When did TC Biopharm's stock split? TC Biopharm shares reverse split on the morning of Monday, August 5th 2024. The 1-10 reverse split was announced on Monday, August 5th 2024. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, August 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did TC Biopharm IPO? TC Biopharm (TCBP) raised $17 million in an initial public offering on Friday, February 11th 2022. The company issued 4,100,000 shares at $4.25 per share. EF Hutton acted as the underwriter for the IPO. How do I buy shares of TC Biopharm? Shares of TCBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TCBP) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
